As of April 1, Burkhart Dental Supply will represent Dentsply Sirona’s full portfolio of dental technology solutions in addition to preventive and restorative solutions it already distributes. The expanded partnership is designed to give dental professionals more comprehensive access to the tools they rely on every day, combining digital technologies, clinical products, and local support to help practices streamline workflows and adopt new technology with confidence. CHARLOTTE, N.C., Feb. 24, 2026 (GLOBE NE ...

Accretive Transaction with Combined Companies’ Pro-Forma Revenue in Excess of $70.00 Million and EBITDA(1) in Excess of $15.75 Million (TTM Sept 30, 2025) MISSISSAUGA, Ontario, Feb. 09, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture (TSXV): RX) announced today that it has entered into a Share Purchase Agreement (“SPA”) dated February 8, 2026 to acquire Oral Science Inc. (“Oral Science”), a privately-owned Canadian distributor of specialized healthcare products for dental hygiene and oral he ...

Group 1: Envista (NVST) - Envista is a global family of over 30 dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr [1] - The company has a Zacks Rank of 1 (Strong Buy) and its current year earnings estimate increased by 8.8% over the last 60 days [1] - Envista's shares gained 45.1% over the last three months, significantly outperforming the S&P 500's gain of 1.3% [2] - The company possesses a Momentum Score of A [2] Group 2: Banco Bilbao Viscaya Argentaria (BBVA) - Banco Bilbao Viscaya Argentaria is engaged in a variety of banking and financial activities in Spain [2] - The company has a Zacks Rank of 1 and its current year earnings estimate increased by 17.7% over the last 60 days [2] - BBVA's shares gained 14.2% over the last three months, also outperforming the S&P 500's gain of 1.3% [3] - The company possesses a Momentum Score of A [3] Group 3: Plexus (PLXS) - Plexus is a leading provider of electronic contract manufacturing services to OEMs across various industries, including Healthcare/Life Sciences, Industrial, and Aerospace/Defense [4] - The company has a Zacks Rank of 1 and its current year earnings estimate increased by 1.6% over the last 60 days [4] - Plexus' shares gained 41.2% over the last three months, outperforming the S&P 500's gain of 1.3% [5] - The company possesses a Momentum Score of A [5]

Core Insights - Solventum Corporation (NYSE:SOLV) is currently viewed as a highly profitable stock, with recent upgrades from Mizuho and Stifel indicating a positive outlook for the company and its market segments [1][2]. Group 1: Company Performance and Upgrades - Mizuho upgraded Solventum from Neutral to Outperform, raising its price target to $100 from $85, based on an optimistic outlook for the dental industry and increased patient volumes [1]. - Stifel also raised its price target for Solventum to $105 from $88 while maintaining a Buy rating, citing a favorable outlook for large-cap MedTech in 2026 [2]. Group 2: Acquisition Details - Solventum finalized its acquisition of Acera Surgical for an upfront cash payment of $725 million, with potential additional milestone payments of up to $125 million, aimed at enhancing its MedSurg portfolio in US acute care settings [3]. - The acquisition is expected to be slightly dilutive to adjusted EPS in 2026 but projected to become accretive starting in 2027 [3]. Group 3: Company Overview - Solventum Corporation develops, manufactures, and commercializes solutions addressing critical healthcare needs, operating in three segments: Medsurg, Dental Solutions, and Health Information Systems [4].

Core Insights - Envista Holdings Corporation reported a strong performance in Q4 2025, achieving 10.8% core revenue growth and 22% adjusted EBITDA growth, with positive growth across all major businesses and geographies [2][6] - For the full year 2025, the company recorded a 6.5% core revenue growth and a 26% EBITDA growth, alongside a significant return of $166 million to shareholders through share repurchases [2][6] Financial Highlights - Q4 2025 financials included sales of $751 million, GAAP net income of $33 million, and adjusted EBITDA of $111 million, reflecting a 22% year-on-year increase [4][6] - For FY 2025, total sales reached $2,719 million, with GAAP net income of $47 million and adjusted EBITDA of $372 million, marking a 26% increase year-on-year [4][6] Cash Flow - Operating cash flow for Q4 2025 was $108 million, while free cash flow was $92 million, down from $132 million and $124 million in Q4 2024 respectively [5][7] - For the full year 2025, operating cash flow totaled $276 million and free cash flow was $231 million, compared to $337 million and $303 million in 2024 [7] Share Repurchases - In Q4 2025, the company repurchased 1.2 million shares for approximately $24 million, and for the full year, 9.2 million shares were repurchased for about $166 million [8] Outlook - The company provided guidance for 2026, projecting core sales growth of 2% to 4%, adjusted EBITDA growth of 7% to 13%, and adjusted diluted earnings per share between $1.35 and $1.45 [9]

At the outset of our career, everyone has a story to relate to something which has brought a change in their life. Let me begin with something like that. So a few years back a woman from Europe walked into my clinic in Hyderabad.She hadn't smiled in public for nearly a decade. She had lost her teeth, her confidence, and a big part of her identity. Every surgeon she met had told her the same thing.You don't have enough bone. You need multiple grafts. And it will take months, maybe a year before you can smile ...

Market Overview - The global dental market was valued at US$ 37.91 billion in 2024 and is projected to reach US$ 67.86 billion by 2033, with a CAGR of 7.55% from 2025 to 2033 [1]. Demand Drivers - The increasing prevalence of dental disorders is significantly influencing demand, with 36 million Americans currently living without any natural teeth, highlighting the urgent need for effective implant and denture solutions [2]. - An additional 120 million people in the U.S. are missing at least one tooth, driving demand for crowns, bridges, and implant restorations [3]. Technological Advancements - CAD/CAM milling technology is transforming dental restoration fabrication, allowing for exceptional precision and consistency in producing crowns, bridges, and veneers [4]. - Over 90,000 dental clinics worldwide have integrated chairside milling stations, enhancing efficiency and patient convenience by allowing restorations to be fabricated and fitted within the same appointment [5]. - Approximately 600,000 dentists globally have completed CAD/CAM training, ensuring high-quality restorations and optimized treatment outcomes [6]. Material Innovations - Adhesives and bonding agents account for a significant 35% share in various clinical procedures, enhancing the strength and stability of dental treatments [7]. - A study indicated that the use of universal bonding agents can increase bond strength from 8 megapascals to nearly 30, improving the durability of restorations [8]. - Adhesives are fundamental in over 60 million composite restoration procedures annually in the U.S., underscoring the critical demand for reliable adhesives [9]. Digital Dentistry - Digital dentistry has captured over 34% of the market share, streamlining clinical workflows and enhancing patient experiences [11]. - Approximately 40,000 digital scanners were operational in U.S. dental practices as of 2021, reflecting the growing confidence in technology-driven diagnostics [12]. - Digital impression systems improve the fit of dental restorations, reducing the need for adjustments and enhancing clinical efficiency [13]. Regional Insights - North America commands over 40% of the global dental market share, driven by the U.S. and Canada, with significant investments in modernizing dental practices [14]. - The U.S. has over 200,000 practicing dentists, ensuring access to essential oral health interventions [15]. - Dental disorders result in over 164 million work hours lost annually in the U.S., highlighting the economic impact of untreated conditions [16]. Key Players - Prominent players in the dental market include 3M Company, Ivoclar Vivadent, GC Corporation, and Dentsply Sirona, among others [19].

Core Insights - Dentsply Sirona has appointed Donald Zurbay to its Board of Directors, effective January 10, 2026, to enhance its governance and support its Return-to-Growth Action Plan [1][3][4] Group 1: Appointment of Donald Zurbay - Mr. Zurbay brings over 30 years of experience in finance and accounting, with significant leadership roles in the dental and healthcare industries, including his recent position as President and CEO of Patterson Companies [2][7] - His familiarity with Dentsply Sirona stems from a longstanding partnership between Patterson and the Company, which will aid in strategic decision-making [2][3] - The Board's Corporate Governance and Nominating Committee led Mr. Zurbay's appointment, increasing the Board size from 10 to 11 members [3] Group 2: Growth and Value Creation Committee - A new four-member Growth and Value Creation Committee has been established, co-chaired by the Board Chairman and the Company's President & CEO, to oversee the Return-to-Growth action plan [5][6] - The Board is committed to actively engaging with management to monitor progress, evaluate growth opportunities, and ensure alignment with strategic priorities [6] - This governance structure aims to facilitate timely decision-making and disciplined oversight, enhancing the execution of the growth strategy [6] Group 3: Company Overview - Dentsply Sirona is the largest diversified manufacturer of professional dental products and technologies, with a history of over a century in the dental industry [8] - The Company offers a comprehensive range of dental and oral health products, as well as consumable medical devices, under a strong portfolio of world-class brands [8] - Dentsply Sirona is headquartered in Charlotte, North Carolina, and its shares are listed on Nasdaq under the symbol XRAY [8]

Core Viewpoint - Envista is positioned as a leader in the dental industry with a focus on growth, operations, and people as part of its new value creation plan [4]. Group 1: Company Overview - Envista has been a leader in the dental industry for over 100 years, indicating its long-standing presence and expertise [3]. - The company is part of the med tech sector, which is characterized by several structurally attractive growth drivers [3]. Group 2: Value Creation Plan - In Q1 of the previous year, Envista introduced a new value creation plan that emphasizes three priority areas: growth, operations, and people [4]. - The presentation will provide an update on the progress of this value creation plan [4].

We partner with dental professionals to improve patients' lives JPM Healthcare Conference 01/01/2025 January 12, 2026 JPM Conference 2026 Forward looking statements/Non-GAAP financial measures FORWARD-LOOKING STATEMENTS Certain statements in this presentation are "forward-looking statements" within the meaning of the U.S. federal securities laws, including statements regarding future financial performance, and the objectives and expectations of management. Terminology such as "believe," "anticipate," "shoul ...